全国性回顾性队列研究显示C3和可溶性C5b-9水平对C3肾小球病肾脏结局的影响
该研究基于法国国家登记处165例C3肾小球病(C3G)患者,回顾性评估C3、可溶性C5b-9(sC5b-9)、C3肾炎因子及补体基因罕见致病变异对肾脏结局的预测价值。多变量分析显示成人发病、估算肾小球滤过率低于60ml/min及补体基因罕见致病变异预测进展至肾衰竭;正常C3/高sC5b-9或低C3/正常sC5b-9独立关联更差肾脏预后,相对风险分别高3.7倍和8倍。作者提出基于生物标志物谱、基线eGFR和遗传发现的成人三点预后评分。
要点
- 成人发病、eGFR低于60ml/min及补体基因罕见致病变异预测C3G进展至肾衰竭。
- 正常C3/高sC5b-9或低C3/正常sC5b-9独立关联更差肾脏预后,相对风险分别高3.7倍和8倍。
- 补体生物标志物谱仅与成人C3G肾脏预后独立相关,儿童仅补体基因罕见致病变异与肾脏生存相关。
核心结论
- 在成人C3G人群中,基于风险生物标志物谱、基线eGFR和遗传发现的三点预后评分可能有助于分层需密切监测和更积极治疗的患者。
研究设计与样本
- 法国国家登记处165例C3G患者的全国性回顾性队列研究,评估C3、sC5b-9、C3肾炎因子及补体基因罕见致病变异的预后价值。
主要发现
- 多变量分析显示成人发病、eGFR低于60ml/min及补体基因罕见致病变异预测进展至肾衰竭。
- 正常C3/高sC5b-9或低C3/正常sC5b-9独立关联更差肾脏预后,相对风险分别高3.7倍和8倍。
- 亚组分析显示补体生物标志物谱与成人而非儿童C3G肾脏预后独立相关。
- 成人亚组中C3和/或sC5b-9谱与肾小球内炎症相关,可能解释肾脏结局。
- 儿童中仅补体基因罕见致病变异与肾脏生存相关。
临床怎么用
- 作者提出在成人C3G中采用基于风险生物标志物谱、基线eGFR和遗传发现的三点预后评分,可能有助于分层需密切监测和更积极治疗的患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
C3 glomerulopathy (C3G) is a rare complement-mediated disease. Specific treatments are not yet available and factors predictive of kidney survival such as age, kidney function and proteinuria are not specific to C3G. The prognostic value of biomarkers of complement activation, which are pathognomonic of the diseases, remains unknown. In a large cohort of 165 patients from the French National registry, we retrospectively assess the prognostic value of C3, soluble C5b-9 (sC5b-9), C3 nephritic factor, and rare disease-predicting variants in complement genes in predicting clinical outcome of patients. By multivariate analysis age (adult onset), reduced kidney function (defined by estimated glomerular filtration rate under 60ml/min) and presence of rare disease-predicting variants in complement genes predicted risk of progression to kidney failure. Moreover, by multivariate analysis, normal C3/high sC5b-9 levels or low C3/normal sC5b-9 levels remained independently associated with a worse kidney prognosis, with the relative risk 3.7- and 8-times higher, respectively. Subgroup analysis indicated that the complement biomarker profiles independently correlated to kidney prognosis in patients with adult but not pediatric onset. In this subgroup, we showed that profiles of biomarkers C3 and/or sC5b-9 correlated with intra glomerular inflammation and may explain kidney outcomes. In children, only the presence of rare disease-predicting variants correlated with kidney survival. Thus, in an adult population, we propose a three-point C3G prognostic score based on biomarker profiles at risk, estimated glomerular filtration rate at presentation and genetic findings, which may help stratify adult patients into subgroups that require close monitoring and more aggressive therapy.
引用
- Chauvet S, Hauer JJ, Petitprez F, et al. Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy. Kidney Int. 2022. PMID: 35752323. doi:10.1016/j.kint.2022.05.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。